Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: Another arrow at the bow?

Cancer Investigation

Volumn 24, Issue 4, 2006, Pages 466-468

  Fabi, A ^a   Vidiri, A ^a   Ferretti, G ^a   Felici, A ^a   Papaldo, P ^a   Carlini, P ^a   Mirri, A ^a   Nuzzo, C ^a   Cognetti, F ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Brain metastasis; Capecitabine breast cancer

Indexed keywords

CAPECITABINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE; TEMOZOLOMIDE; THALIDOMIDE; THYMIDINE PHOSPHORYLASE; TRASTUZUMAB;

ADULT; ARTICLE; BRAIN EDEMA; BRAIN METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; DRUG ACTIVATION; DRUG PENETRATION; DRUG TUMOR LEVEL; FEMALE; HUMAN; PRIORITY JOURNAL;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; BREAST NEOPLASMS; DEOXYCYTIDINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 33745317987     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900600705805     Document Type: Article

References (12)

1. Batchelor, T.T.; Gatineau, M.P.; Supko, J.G. Pharmacologic considerations in chemotherapy for brain tumors. In Cancer Chemotherapy and Biotherapy: Principles and Practice, Chabner, B.A., Longo, D.L., eds. (Philadelphia, Lippincott Williams & Wilkins, 2001).
2. Cordon-Cardo, C.; O'Brien, J.P.; Casals, D. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 1989, 86, 695-698.
3. Lin, N.U.; Bellon, J.R.; Winer, E.P. CNS metastases in breast cancer. J. Clin. Oncol. 2004, 22(17), 3608-3617.
4. Rosner, D.; Nemoto, T.; Lane, W.W. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 1986, 58, 832-839.
5. Boogerd, W.; Dalesio, O.; Bais, E.M.; van der Sande, J.J. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992, 69 (4), 972-980.
6. Tsukamoto, Y.; Kato, Y.; Ura, M.; Horii, I.; Ishitsuka, H.; Kusuhara, H.; Sugiyama, Y. A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU. Pharm. Res. 2001, 18, 1190-1202.
7. Ishikawa, T.; Fukase, Y.; Yamamoto, T.; Sekiguchi, F.; Ishitsuka, H. Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5′- deoxy-5-fluorocytidine (capecitabine). Biol. Pharm. Bull. 1998, 21, 713-717.
8. Ishikawa, T.; Sekiguchi, F.; Fukase, Y.; Sawada, N.; Ishitsuka, H. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res. 1998, 58, 685-690.
9. Wang, M.L.H.; Yung, W.K.; Royce, M.E.; Schomer, D.F.; Theriault, R.L. Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer. Am. J. Clin. Oncol. 2001, 24 (4), 421-424.
10. Blanquicett, C.; Gillespie, G.Y.; Nabors, L.B.; Miller, C.R.; Bharara, S.; Buchsbaum, D.J.; Diasio, R.B.; Johnson, M.R. Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation. Mol. Cancer Ther. 2002, 1 (12), 1139-1145.
11. Sawada, N.; Ishikawa, T.; Sekiguchi, F.; Tanaka, Y.; Ishitsuka, H. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin. Cancer Res. 1995, 2948-2953.
12. Wilke, H. Future treatment options with capecitabine in solid tumours. Eur. J. Cancer 2002, 38, 21-25.